Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Synonyms
parp, pertussis toxin, parp-1, poly(adp-ribose) polymerase, parp1, poly (adp-ribose) polymerase, poly(adp-ribose) polymerase-1, c3 exoenzyme, adprt, exoenzyme s,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(adenosine diphosphoribose)transferase, nicotinamide adenine dinucleotide-protein
-
-
-
-
193-kDa vault protein
-
-
-
-
adenosine diphosphate ribosyltransferase
-
-
-
-
ADP-ribosyltransferase
-
-
-
-
ADP-ribosyltransferase (polymerizing)
-
-
-
-
NAD(+) ADP-ribosyltransferase
-
-
-
-
NAD+:ADP-ribosyltransferase (polymerizing)
-
-
-
-
NAD-protein ADP-ribosyltransferase
-
-
-
-
PARP-related/IalphaI-related H5/proline-rich
-
-
-
-
poly(ADP-ribose) polymerase
-
-
-
-
poly(ADP-ribose) polymerase-1
-
-
poly(ADP-ribose) synthase
-
-
-
-
poly(ADP-ribose) transferase
-
-
-
-
poly(ADP-ribosyl)transferase
-
-
-
-
poly[ADP-ribose] synthetase
-
-
-
-
Tankyrase-like protein
-
-
-
-
Tankyrase-related protein
-
-
-
-
TRF1-interacting ankyrin-related ADP-ribose polymerase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
NAD+ + histone H2B
nicotinamide + (ADP-D-ribosyl)-histone H2B
-
-
-
-
?
additional information
?
-
-
cuts produced in vivo on DNA during DNA repair activate the enzyme, which then synthesiszes poly(ADP-ribose) on histone H1, in particular, and contributes to the opening of the 25 nm chromatin fiber, resulting in the increased accessibility of DNA to excision repair enzymes
-
-
?
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
-
-
-
-
?
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
-
poly(ADP-ribosyl)ation of histone H1
-
-
?
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
-
the enzyme is a DNA repair enzyme
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1(2H)-phthalazinone
-
IC50: 0.012 mM
1,2-benzopyrone
-
IC50: 2.8 mM
1,3-benzodiazine
-
IC50: 2.0 mM
1,3-dihydroxynaphthalene
-
IC50: 1.3 mM
1,4-benzoquinone
-
IC50: 0.4 mM
1,4-naphthalenedione
-
IC50: 0.25 mM
1,5-dihydroxyisoquinoline
-
IC50: 0.00039 mM
1,8-naphthalimide
-
IC50: 0.0014 mM
1-hydroxy-2-methyl-4-aminonaphthalene
-
IC50: 1.3 mM
1-hydroxyisoquinoline
-
IC50: 0.007 mM
1-Indanone
-
IC50: 0.81 mM
1-methylnicotinamide chloride
2,3-benzodiazine
-
IC50: 0.15 mM
2,3-dichloro-1,4-naphthoquinone
-
IC50: 0.26 mM
2,3-dihydro-1,4-phthalazinedione
-
IC50: 0.03 mM
2,4(1H,3H)-quinazolinedione
-
IC50: 0.0081 mM
2,6-difluorobenzamide
-
IC50: 0.18 mM
2-acetamidobenzamide
-
IC50: 1.0 mM
2-amino-3-chloro-1,4-naphthoquinone
-
IC50: 0.82 mM
2-bromobenzamide
-
IC50: 2.9 mM
2-chlorobenzamide
-
IC50: 1.0 mM
2-fluorobenzamide
-
IC50: 0.12 mM
2-Hydroxy-1,4-naphthoquinone
-
IC50: 0.33 mM
2-hydroxybenzamide
-
IC50: 0.82 mM
2-mercapto-4(3H)-quinazolinone
-
IC50: 0.044 mM
2-Methoxybenzamide
-
IC50: 0.2 mM
2-methyl-1,4-benzopyrone
-
IC50: 0.045 mM
2-methyl-1,4-naphthoquinone
-
IC50: 0.42 mM
2-methyl-3-phytyl-1,4-naphthoquinone
-
IC50: 0.52 mM
2-methyl-4(3H)-quinazolinone
-
IC50: 0.056 mM
2-methylbenzamide
-
IC50: 1.5 mM
2-methylchromone
-
IC50: 0.045 mM
2-nitro-6(5H)-phenanthridione
-
IC50: 0.00035 mM
2-phenylchromone
-
IC50: 0.022 mM
2-trichloromethyl-4(3H)-quinazolinone
-
IC50: 2.2 mM
2H-benz[c]isoquinolin-1-one
-
IC50: 0.0003 mM
2H-benz[de]isoquinoline-1,3-dione
-
IC50: 0.0014 mM
3,4-dihydro-1(2H)-naphthalenone
-
IC50: 0.31 mM
3,5-dibromosalicylamide
-
IC50: 0.56 mM
3,5-dimethoxybenzamide
-
IC50: 1.2 mM
3,5-dinitrobenzamide
-
IC50: 2.5 mM
3-(N,N-dimethylamino)benzamide
-
IC50: 0.12 mM
3-Acetamidobenzamide
-
IC50: 0.012 mM
3-acetamidosalicylamide
-
IC50: 2.0 mM
3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole
-
i.e. Trp-P-1, 94% inhibition at 5 mM, IC50: 0.22 mM
3-amino-1-methyl-5H-pyrido[4,3-b]indole
-
i.e. Trp-P-2, 34% activation at 1 mM, 7% inhibition at 5 mM, IC50: 2.2 mM
3-Aminophthalhydrazide
-
IC50: 0.023 mM
3-bromobenzamide
-
IC50: 0.055 mM
3-Chlorobenzamide
-
IC50: 0.22 mM
3-Fluorobenzamide
-
IC50: 0.2 mM
3-Hydroxybenzamide
-
IC50: 0.0091 mM
3-isobutyl-1-methylxanthine
-
IC50: 3.1 mM
3-Methylbenzamide
-
IC50: 0.19 mM
3-nitrobenzamide
-
IC50: 0.16 mM
3-nitrophthalhydrazide
-
IC50: 0.072 mM
3-nitrosalicylamide
-
IC50: 1.6 mM
4,8-dihydroxy-2-quinolinecarboxylic acid
-
IC50: 0.19 mM
4-amino-1,8-naphthalimide
-
IC50: 0.00018 mM
4-aminophthalhydrazide
-
IC50: 0.29 mM
4-bromobenzamide
-
IC50: 2.2 mM
4-chlorobenzamide
-
IC50: 0.3 mM
4-chromanone
-
IC50: 0.72 mM
4-fluorobenzamide
-
IC50: 0.2 mM
4-hydroxy-2-methylquinoline
-
IC50: 0.074 mM
4-hydroxy-2-quinolinecarboxylic acid
-
IC50: 0.67 mM
4-hydroxybenzamide
-
IC50: 0.28 mM
4-Hydroxycoumarin
-
IC50: 0.57 mM
4-hydroxypyridine
-
IC50: 2.3 mM
4-hydroxyquinazoline
-
IC50: 0.0095 mM
4-hydroxyquinoline
-
IC50: 0.08 mM
4-methoxybenzamide
-
IC50: 1.1 mM
4-methylbenzamide
-
IC50: 1.8 mM
4-nitrophthalhydrazide
-
IC50: 0.51 mM
4-[[[6-cyano-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4,6,7-hexahydroquinolin-3-yl](pyridin-2-ylsulfonyl)amino]methyl]-N,N-dimethylpiperidine-1-carboxamide
-
activates in presence of Mg2+, inhibits in absence of Mg2+
5-acetamidosalicylamide
-
IC50: 0.045 mM
5-aminosalicylamide
-
IC50: 0.1 mM
5-bromodeoxyuridine
-
IC50: 0.015 mM
5-Bromouracil
-
IC50: 0.16 mM
5-Bromouridine
-
IC50: 0.21 mM
5-chlorosalicylamide
-
IC50: 0.19 mM
5-Chlorouracil
-
IC50: 0.27 mM
5-hydroxy-1,4-naphthoquinone
-
IC50: 0.25 mM
5-Hydroxy-2-methyl-1,4-naphthoquinone
-
IC50: 0.7 mM
5-Iodouracil
-
IC50: 0.071 mM
5-iodouridine
-
IC50: 0.043 mM
5-methyluracil
-
IC50: 0.29 mM
5-Nitrouracil
-
IC50: 0.43 mM
6(5H)-phenanthridinone
-
IC50: 0.0003 mM
6-aminocoumarin
-
IC50: 0.85 mM
6-aminonicotinamide
-
IC50: 1.1 mM
8-acetamidocarsalam
-
IC50: 1.4 mM
8-Methylnicotinamide
-
IC50: 7.8 mM
acetophenone
-
IC50: 2.3 mM
all-trans-retinal
-
IC50: 0.45 mM
alpha-picolinamide
-
IC50: 0.25 mM
benzoyleneurea
-
IC50: 0.0081 mM
carbonylsalicylamide
-
IC50: 0.46 mM
carsalam
-
5 mM, 88% inhibition in presence of Mg2+, 68% inhibition in absence of Mg2+
Chlorthenoxazin
-
IC50: 0.0085 mM
chromone-2-carboxylic acid
-
IC50: 0.56 mM
cyclohexanecarboxamide
-
IC50: 0.62 mM
EDTA
-
5 mM, 41% inhibition in presence of Mg2+, 2% inhibition in absence of Mg2+
gamma-linolenic acid
-
IC50: 0.12 mM
hypoxanthine
-
IC50: 1.7 mM
Isonicotinamide
-
IC50: 0.99 mM
Isonicotinate hydrazide
-
IC50: 4.8 MM
Isoquinoline
-
5 mM, 47% inhibition in presence of Mg2+, 34% inhibition in absence of Mg2+
linoleic acid
-
IC50: 0.048 mM
linolenic acid
-
IC50: 0.11 mM
m-acetamidoacetophenone
-
IC50: 0.93 mM
m-aminoacetophenone
-
IC50: 1.9 mM
m-hydroxyacetophenone
-
IC50: 0.6 mM
m-phthalamide
-
IC50: 0.05 mM
menadione sodium bisulfite
-
IC50: 0.72 mM
N-(2-chloroethyl)1,8-naphthalamide
-
IC50: above 1.8 mM
N-hydroxynaphthalimide sodium salt
-
IC50: 0.45 mM
novobiocin
-
IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+
oleic acid
-
IC50: 0.082 mM
palmitoleic acid
-
IC50: 0.095 mM
phthalamide
-
IC50: 1.0 mM
Phthalazine
-
5 mM, 91% inhibition in presence of Mg2+, 79% inhibition in absence of Mg2+
Pyrazinamide
-
IC50: 0.13 mM
Quinazoline
-
5 mM, 63% inhibition in presence of Mg2+, 50% inhibition in absence of Mg2+
reserpine
-
IC50: 0.79 mM
Theobromine
-
IC50: 0.11 mM
theophylline
-
IC50: 0.0046
thiobenzamide
-
IC50: 0.62 mM
Thionicotinamide
-
IC50: 1.8 mM
trans-decahydro-1-naphthalenone
-
IC50: 4.3 mM
vitamin K1
-
IC50: 0.0019 mM
vitamin K3
-
IC50: 0.42 mM
xanthurenic acid
-
5 mM, 88% inhibition in presence of Mg2+, 65% inhibition in absence of Mg2+
Zn2+
-
ZnCl2, IC50: 0.077 mM
additional information
-
comparison of the effects of heterocyclic amines acting as potent carcinogens on PARP-1 and the arginine-specific mono-ADP-ribosyltransferase A, MART-A, EC 2.4.2.31, overview
-
1-methylnicotinamide chloride
-
IC50: 3.8 mM
1-methylnicotinamide chloride
-
IC50: 1.7 mM
2-Aminobenzamide
-
IC50: 0.65 mM
2-Aminobenzamide
-
IC50: 0.1 mM
3-aminobenzamide
-
IC50: 0.33 mM
3-aminobenzamide
-
IC50: 0.0054
3-Methoxybenzamide
-
IC50: 0.017 mM
3-Methoxybenzamide
-
IC50: 0.0034 mM
4-Aminobenzamide
-
IC50: 1.8 mM
4-Aminobenzamide
-
IC50: 0.4 mM
5-Methylnicotinamide
-
IC50: 0.35 mM
5-Methylnicotinamide
-
IC50: 0.07
Benzamide
-
IC50: 0.22 mM
Benzamide
-
IC50: 0.0033 mM
nicotinamide
-
IC50: 0.21 mM
nicotinamide
-
IC50: 0.031 mM
thymidine
-
IC50: 0.18 mM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3-amino-1-methyl-5H-pyrido[4,3-b]indole
-
i.e. Trp-P-2, 34% activation at 1 mM, 7% inhibition at 5 mM, IC50: 2.2 mM
4-[[[6-cyano-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4,6,7-hexahydroquinolin-3-yl](pyridin-2-ylsulfonyl)amino]methyl]-N,N-dimethylpiperidine-1-carboxamide
-
activates in presence of Mg2+, inhibits in absence of Mg2+
DNA
-
the enzyme is completely dependent on the presence of DNA containing single or double stranded breaks. Activation results in a decondensation of chromatin superstructure in vitro, which is caused mainly by hyper(ADP-ribosyl)ation of histone H1
harmaline hydrochloride
-
activates more strongly in absence of Mg2+ than in presence of Mg2+
Phthalic acid
-
activates more strongly in absence of Mg2+ than in presence of Mg2+
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.012
1(2H)-phthalazinone
Bos taurus
-
IC50: 0.012 mM
2.8
1,2-benzopyrone
Bos taurus
-
IC50: 2.8 mM
2
1,3-benzodiazine
Bos taurus
-
IC50: 2.0 mM
1.3
1,3-dihydroxynaphthalene
Bos taurus
-
IC50: 1.3 mM
0.4
1,4-benzoquinone
Bos taurus
-
IC50: 0.4 mM
0.25
1,4-naphthalenedione
Bos taurus
-
IC50: 0.25 mM
0.00039
1,5-dihydroxyisoquinoline
Bos taurus
-
IC50: 0.00039 mM
0.0014
1,8-naphthalimide
Bos taurus
-
IC50: 0.0014 mM
1.3
1-hydroxy-2-methyl-4-aminonaphthalene
Bos taurus
-
IC50: 1.3 mM
0.007
1-hydroxyisoquinoline
Bos taurus
-
IC50: 0.007 mM
0.81
1-Indanone
Bos taurus
-
IC50: 0.81 mM
1.7 - 3.8
1-methylnicotinamide chloride
0.15
2,3-benzodiazine
Bos taurus
-
IC50: 0.15 mM
0.26
2,3-dichloro-1,4-naphthoquinone
Bos taurus
-
IC50: 0.26 mM
0.03
2,3-dihydro-1,4-phthalazinedione
Bos taurus
-
IC50: 0.03 mM
0.0081
2,4(1H,3H)-quinazolinedione
Bos taurus
-
IC50: 0.0081 mM
0.18
2,6-difluorobenzamide
Bos taurus
-
IC50: 0.18 mM
1
2-acetamidobenzamide
Bos taurus
-
IC50: 1.0 mM
0.82
2-amino-3-chloro-1,4-naphthoquinone
Bos taurus
-
IC50: 0.82 mM
0.1 - 0.65
2-Aminobenzamide
2.9
2-bromobenzamide
Bos taurus
-
IC50: 2.9 mM
1
2-chlorobenzamide
Bos taurus
-
IC50: 1.0 mM
0.12
2-fluorobenzamide
Bos taurus
-
IC50: 0.12 mM
0.33
2-Hydroxy-1,4-naphthoquinone
Bos taurus
-
IC50: 0.33 mM
0.82
2-hydroxybenzamide
Bos taurus
-
IC50: 0.82 mM
0.044
2-mercapto-4(3H)-quinazolinone
Bos taurus
-
IC50: 0.044 mM
0.2
2-Methoxybenzamide
Bos taurus
-
IC50: 0.2 mM
0.045
2-methyl-1,4-benzopyrone
Bos taurus
-
IC50: 0.045 mM
0.42
2-methyl-1,4-naphthoquinone
Bos taurus
-
IC50: 0.42 mM
0.52
2-methyl-3-phytyl-1,4-naphthoquinone
Bos taurus
-
IC50: 0.52 mM
0.056
2-methyl-4(3H)-quinazolinone
Bos taurus
-
IC50: 0.056 mM
1.5
2-methylbenzamide
Bos taurus
-
IC50: 1.5 mM
0.045
2-methylchromone
Bos taurus
-
IC50: 0.045 mM
0.00035
2-nitro-6(5H)-phenanthridione
Bos taurus
-
IC50: 0.00035 mM
0.022
2-phenylchromone
Bos taurus
-
IC50: 0.022 mM
2.2
2-trichloromethyl-4(3H)-quinazolinone
Bos taurus
-
IC50: 2.2 mM
0.0003
2H-benz[c]isoquinolin-1-one
Bos taurus
-
IC50: 0.0003 mM
0.0014
2H-benz[de]isoquinoline-1,3-dione
Bos taurus
-
IC50: 0.0014 mM
0.31
3,4-dihydro-1(2H)-naphthalenone
Bos taurus
-
IC50: 0.31 mM
0.56
3,5-dibromosalicylamide
Bos taurus
-
IC50: 0.56 mM
1.2
3,5-dimethoxybenzamide
Bos taurus
-
IC50: 1.2 mM
2.5
3,5-dinitrobenzamide
Bos taurus
-
IC50: 2.5 mM
0.12
3-(N,N-dimethylamino)benzamide
Bos taurus
-
IC50: 0.12 mM
0.012
3-Acetamidobenzamide
Bos taurus
-
IC50: 0.012 mM
2
3-acetamidosalicylamide
Bos taurus
-
IC50: 2.0 mM
0.22
3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole
Bos taurus
-
i.e. Trp-P-1, 94% inhibition at 5 mM, IC50: 0.22 mM
2.2
3-amino-1-methyl-5H-pyrido[4,3-b]indole
Bos taurus
-
i.e. Trp-P-2, 34% activation at 1 mM, 7% inhibition at 5 mM, IC50: 2.2 mM
0.0054 - 0.33
3-aminobenzamide
0.023
3-Aminophthalhydrazide
Bos taurus
-
IC50: 0.023 mM
0.055
3-bromobenzamide
Bos taurus
-
IC50: 0.055 mM
0.22
3-Chlorobenzamide
Bos taurus
-
IC50: 0.22 mM
0.2
3-Fluorobenzamide
Bos taurus
-
IC50: 0.2 mM
0.0091
3-Hydroxybenzamide
Bos taurus
-
IC50: 0.0091 mM
3.1
3-isobutyl-1-methylxanthine
Bos taurus
-
IC50: 3.1 mM
0.0034 - 0.017
3-Methoxybenzamide
0.19
3-Methylbenzamide
Bos taurus
-
IC50: 0.19 mM
0.16
3-nitrobenzamide
Bos taurus
-
IC50: 0.16 mM
0.072
3-nitrophthalhydrazide
Bos taurus
-
IC50: 0.072 mM
1.6
3-nitrosalicylamide
Bos taurus
-
IC50: 1.6 mM
0.19
4,8-dihydroxy-2-quinolinecarboxylic acid
Bos taurus
-
IC50: 0.19 mM
0.00018
4-amino-1,8-naphthalimide
Bos taurus
-
IC50: 0.00018 mM
0.4 - 1.8
4-Aminobenzamide
0.29
4-aminophthalhydrazide
Bos taurus
-
IC50: 0.29 mM
2.2
4-bromobenzamide
Bos taurus
-
IC50: 2.2 mM
0.3
4-chlorobenzamide
Bos taurus
-
IC50: 0.3 mM
0.72
4-chromanone
Bos taurus
-
IC50: 0.72 mM
0.2
4-fluorobenzamide
Bos taurus
-
IC50: 0.2 mM
0.074
4-hydroxy-2-methylquinoline
Bos taurus
-
IC50: 0.074 mM
0.67
4-hydroxy-2-quinolinecarboxylic acid
Bos taurus
-
IC50: 0.67 mM
0.28
4-hydroxybenzamide
Bos taurus
-
IC50: 0.28 mM
0.57
4-Hydroxycoumarin
Bos taurus
-
IC50: 0.57 mM
2.3
4-hydroxypyridine
Bos taurus
-
IC50: 2.3 mM
0.0095
4-hydroxyquinazoline
Bos taurus
-
IC50: 0.0095 mM
0.08
4-hydroxyquinoline
Bos taurus
-
IC50: 0.08 mM
1.1
4-methoxybenzamide
Bos taurus
-
IC50: 1.1 mM
1.8
4-methylbenzamide
Bos taurus
-
IC50: 1.8 mM
0.51
4-nitrophthalhydrazide
Bos taurus
-
IC50: 0.51 mM
0.045
5-acetamidosalicylamide
Bos taurus
-
IC50: 0.045 mM
0.1
5-aminosalicylamide
Bos taurus
-
IC50: 0.1 mM
0.015
5-bromodeoxyuridine
Bos taurus
-
IC50: 0.015 mM
0.16
5-Bromouracil
Bos taurus
-
IC50: 0.16 mM
0.21
5-Bromouridine
Bos taurus
-
IC50: 0.21 mM
0.19
5-chlorosalicylamide
Bos taurus
-
IC50: 0.19 mM
0.27
5-Chlorouracil
Bos taurus
-
IC50: 0.27 mM
0.25
5-hydroxy-1,4-naphthoquinone
Bos taurus
-
IC50: 0.25 mM
0.7
5-Hydroxy-2-methyl-1,4-naphthoquinone
Bos taurus
-
IC50: 0.7 mM
0.071
5-Iodouracil
Bos taurus
-
IC50: 0.071 mM
0.043
5-iodouridine
Bos taurus
-
IC50: 0.043 mM
0.07 - 0.35
5-Methylnicotinamide
0.29
5-methyluracil
Bos taurus
-
IC50: 0.29 mM
0.43
5-Nitrouracil
Bos taurus
-
IC50: 0.43 mM
0.0003
6(5H)-phenanthridinone
Bos taurus
-
IC50: 0.0003 mM
0.85
6-aminocoumarin
Bos taurus
-
IC50: 0.85 mM
1.1
6-aminonicotinamide
Bos taurus
-
IC50: 1.1 mM
1.4
8-acetamidocarsalam
Bos taurus
-
IC50: 1.4 mM
7.8
8-Methylnicotinamide
Bos taurus
-
IC50: 7.8 mM
2.3
acetophenone
Bos taurus
-
IC50: 2.3 mM
0.45
all-trans-retinal
Bos taurus
-
IC50: 0.45 mM
0.25
alpha-picolinamide
Bos taurus
-
IC50: 0.25 mM
0.0081
benzoyleneurea
Bos taurus
-
IC50: 0.0081 mM
1.4
Caffeine
Bos taurus
-
IC50: 1.4 mM
0.46
carbonylsalicylamide
Bos taurus
-
IC50: 0.46 mM
0.0085
Chlorthenoxazin
Bos taurus
-
IC50: 0.0085 mM
0.56
chromone-2-carboxylic acid
Bos taurus
-
IC50: 0.56 mM
0.62
cyclohexanecarboxamide
Bos taurus
-
IC50: 0.62 mM
0.022
flavone
Bos taurus
-
IC50: 0.022 mM
0.12
gamma-linolenic acid
Bos taurus
-
IC50: 0.12 mM
1.7
hypoxanthine
Bos taurus
-
IC50: 1.7 mM
0.99
Isonicotinamide
Bos taurus
-
IC50: 0.99 mM
4.8
Isonicotinate hydrazide
Bos taurus
-
IC50: 4.8 mM
0.048
linoleic acid
Bos taurus
-
IC50: 0.048 mM
0.11
linolenic acid
Bos taurus
-
IC50: 0.11 mM
0.93
m-acetamidoacetophenone
Bos taurus
-
IC50: 0.93 mM
1.9
m-aminoacetophenone
Bos taurus
-
IC50: 1.9 mM
0.6
m-hydroxyacetophenone
Bos taurus
-
IC50: 0.6 mM
0.05
m-phthalamide
Bos taurus
-
IC50: 0.05 mM
0.72
menadione sodium bisulfite
Bos taurus
-
IC50: 0.72 mM
1.8
N-(2-chloroethyl)1,8-naphthalamide
Bos taurus
-
IC50: above 1.8 mM
0.45
N-hydroxynaphthalimide sodium salt
Bos taurus
-
IC50: 0.45 mM
0.031 - 0.21
nicotinamide
4.7
norharman
Bos taurus
-
IC50: 4.7 mM
2.2
novobiocin
Bos taurus
-
IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+
0.082
oleic acid
Bos taurus
-
IC50: 0.082 mM
0.095
palmitoleic acid
Bos taurus
-
IC50: 0.095 mM
1
phthalamide
Bos taurus
-
IC50: 1.0 mM
0.13
Pyrazinamide
Bos taurus
-
IC50: 0.13 mM
0.79
reserpine
Bos taurus
-
IC50: 0.79 mM
0.11
Theobromine
Bos taurus
-
IC50: 0.11 mM
0.046
theophylline
Bos taurus
-
IC50: 0.046 mM
0.62
thiobenzamide
Bos taurus
-
IC50: 0.62 mM
1.8
Thionicotinamide
Bos taurus
-
IC50: 1.8 mM
4.3
trans-decahydro-1-naphthalenone
Bos taurus
-
IC50: 4.3 mM
0.0019
vitamin K1
Bos taurus
-
IC50: 0.0019 mM
0.42
vitamin K3
Bos taurus
-
IC50: 0.42 mM
0.077
Zn2+
Bos taurus
-
ZnCl2, IC50: 0.077 mM
1.7
1-methylnicotinamide chloride
Bos taurus
-
IC50: 1.7 mM
3.8
1-methylnicotinamide chloride
Bos taurus
-
IC50: 3.8 mM
0.1
2-Aminobenzamide
Bos taurus
-
IC50: 0.1 mM
0.65
2-Aminobenzamide
Bos taurus
-
IC50: 0.65 mM
0.0054
3-aminobenzamide
Bos taurus
-
IC50: 0.0054
0.33
3-aminobenzamide
Bos taurus
-
IC50: 0.33 mM
0.0034
3-Methoxybenzamide
Bos taurus
-
IC50: 0.0034 mM
0.017
3-Methoxybenzamide
Bos taurus
-
IC50: 0.017 mM
0.4
4-Aminobenzamide
Bos taurus
-
IC50: 0.4 mM
1.8
4-Aminobenzamide
Bos taurus
-
IC50: 1.8 mM
0.07
5-Methylnicotinamide
Bos taurus
-
IC50: 0.07 mM
0.35
5-Methylnicotinamide
Bos taurus
-
IC50: 0.35 mM
0.0033
Benzamide
Bos taurus
-
IC50: 0.0033 mM
0.22
Benzamide
Bos taurus
-
IC50: 0.22 mM
0.031
nicotinamide
Bos taurus
-
IC50: 0.031 mM
0.21
nicotinamide
Bos taurus
-
IC50: 0.21 mM
0.043
thymidine
Bos taurus
-
IC50: 0.043 mM
0.18
thymidine
Bos taurus
-
IC50: 0.18 mM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Banasik, M.; Komura, H.; Shimoyama, M.; Ueda, K.
Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase
J. Biol. Chem.
267
1569-1575
1992
Bos taurus
brenda
De Murcia, G.; Huletsky, A.; Poirier, G.G.
Modulation of chromatin structure by poly(ADP-ribosyl)ation
Biochem. Cell Biol.
66
626-635
1988
Bos taurus
brenda
Rankin, P.W.; Jacobson, E.L.; benjamin, R.C.; Moss, J.; Jacobson, M.K.
Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo
J. Biol. Chem.
264
4312-4317
1989
Bos taurus
brenda
Banasik, M.; Stedeford, T.; Strosznajder, R.P.; Hsu, C.H.; Tanaka, S.; Ueda, K.
Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A
J. Physiol. Pharmacol.
57 Suppl 4
15-22
2006
Bos taurus
brenda